Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Brenner Martin sold 4,881 shares at $0.27 ($1,296)
  9. 4 Open-market sale Brenner Martin sold 5,267 shares at $0.30 ($1,592)
  10. 4 Open-market sale Brenner Martin sold 4,215 shares at $0.31 ($1,311)
  11. 4 Open-market sale Brenner Martin sold 5,011 shares at $0.31 ($1,529)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Brenner Martin sold 4,515 shares at an average $0.51 ($2,308)
  15. 4 Open-market sale Brenner Martin sold 47,020 shares at $0.59 ($27,521)
  16. 4 Grant or award Brenner Martin acquired 75,833 shares (grant or award)
  17. 4 Open-market sale Brenner Martin sold 4,184 shares at an average $0.68 ($2,849)
  18. 4 Open-market sale Brenner Martin sold 4,182 shares at an average $0.94 ($3,910)
  19. 4 Open-market sale Brenner Martin sold 4,382 shares at $1.20 ($5,258)
  20. 4 Grant or award Brenner Martin acquired 50,000 shares (grant or award)

Page 3 of 13 · 260 filings